HCPCS Level II · Drugs administered other than oral method
J7311Injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg
✓ Active
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About J7311
J7311 is an HCPCS Level II code in the J series (drugs administered other than oral method), describing injection, fluocinolone acetonide, intravitreal implant (retisert), 0.01 mg.
It was added to HCPCS effective 01/01/2007, and its current record took effect 10/01/2019.
Its Medicare coverage code is "C", meaning coverage is left to the Medicare contractor's judgment.
Details
- Short description
- Inj., retisert, 0.01 mg
- Date added
- 01/01/2007
- Action effective
- 10/01/2019
- BETOS
- O1E
Related J73xx codes
- J7300Intrauterine copper contraceptive (paragard)
- J7301Levonorgestrel-releasing intrauterine contraceptive system (skyla), 13.5 mg
- J7304Contraceptive supply, hormone containing patch, each
- J7306Levonorgestrel (contraceptive) implant system, including implants and supplies
- J7307Etonogestrel (contraceptive) implant system, including implant and supplies
- J7308Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg)
- J7312Injection, dexamethasone, intravitreal implant, 0.1 mg
- J7313Injection, fluocinolone acetonide, intravitreal implant (iluvien), 0.01 mg
- J7314Injection, fluocinolone acetonide, intravitreal implant (yutiq), 0.01 mg
- J7315Mitomycin, ophthalmic, 0.2 mg
- J7316Injection, ocriplasmin, 0.125 mg
- J7318Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg
Common questions about J7311
Is HCPCS J7311 still valid?
- Yes. J7311 is active in the CMS October 2026 HCPCS file.
Does Medicare cover J7311?
- Its coverage code is "C": coverage is left to the Medicare contractor's judgment. Check the local coverage determination for your region.